Leuthold Group LLC Trims Stake in Select Medical Holdings Co. (NYSE:SEM)

Leuthold Group LLC decreased its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 0.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 96,458 shares of the health services provider’s stock after selling 329 shares during the quarter. Leuthold Group LLC owned 0.07% of Select Medical worth $3,363,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Hexagon Capital Partners LLC grew its position in Select Medical by 528.7% during the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock valued at $27,000 after buying an additional 645 shares during the period. Transcendent Capital Group LLC purchased a new stake in shares of Select Medical in the second quarter valued at approximately $35,000. Canada Pension Plan Investment Board acquired a new position in shares of Select Medical during the 2nd quarter worth approximately $39,000. Fidelis Capital Partners LLC acquired a new stake in Select Medical in the 1st quarter valued at $47,000. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Select Medical in the 2nd quarter worth $60,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Down 1.2 %

Shares of NYSE SEM opened at $31.35 on Monday. The stock has a market cap of $4.08 billion, a PE ratio of 15.19, a P/E/G ratio of 1.96 and a beta of 1.41. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 2.11. Select Medical Holdings Co. has a 12-month low of $21.28 and a 12-month high of $40.50. The company has a 50-day moving average of $34.35 and a 200 day moving average of $33.83.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.91% and a return on equity of 17.50%. Select Medical’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the company earned $0.61 earnings per share. As a group, sell-side analysts predict that Select Medical Holdings Co. will post 2.03 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were issued a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.59%. The ex-dividend date was Wednesday, August 14th. Select Medical’s dividend payout ratio is currently 23.92%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on SEM. Benchmark reiterated a “buy” rating and issued a $48.00 target price on shares of Select Medical in a research report on Friday, September 6th. Bank of America began coverage on Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $39.00.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.